Advicenne SA Optimistic as Sibnayal® Sales Surge

Advicenne SA (FR:ALDVI) has released an update.

Advicenne SA reports a 28% increase in gross sales of Sibnayal® driven by strong market adoption, contributing to the company’s progress toward operational profitability expected by early 2025. With a solid cash position of 2.0 million euros, Advicenne anticipates favorable regulatory discussions in the US for ADV7103, indicating a positive outlook for future commercial partnerships.

For further insights into FR:ALDVI stock, check out TipRanks’ Stock Analysis page.